Have a feature idea you'd love to see implemented?
Let us know!
ATNF 180 Life Sciences Corp
Price (delayed)
$2.28
Market cap
$4.51M
P/E Ratio
0.29
Dividend/share
N/A
EPS
$7.78
Enterprise value
$4.8M
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined
Highlights
ATNF's EPS has surged by 149% since the previous quarter and by 103% year-on-year
180 Life Sciences's net income has surged by 92% YoY and by 75% QoQ
The quick ratio has dropped by 95% year-on-year and by 90% since the previous quarter
ATNF's debt is up by 36% year-on-year and by 9% since the previous quarter
Key stats
What are the main financial stats of ATNF
Market
Valuations
Earnings
Shares outstanding
1.98M
Market cap
$4.51M
Enterprise value
$4.8M
Price to earnings (P/E)
0.29
Price to book (P/B)
0.59
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$3.07M
EBITDA
-$2.99M
Free cash flow
-$2.69M
Per share
Balance sheet
Liquidity
EPS
$7.78
Free cash flow per share
-$2.74
Book value per share
$3.85
Revenue per share
$0
TBVPS
$1.25
Total assets
$10.47M
Total liabilities
$6.74M
Debt
$483,717
Equity
$3.73M
Working capital
-$5.16M
Debt to equity
0.13
Current ratio
0.19
Quick ratio
0.03
Net debt/EBITDA
-0.1
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-54.1%
Return on equity
-559.1%
Return on invested capital
N/A
Return on capital employed
-75.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATNF stock price
How has the 180 Life Sciences stock price performed over time
Intraday
-2.56%
1 week
-14.93%
1 month
-54.12%
1 year
-66.67%
YTD
-43.84%
QTD
36.53%
Financial performance
How have 180 Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.37M
Net income
-$3.12M
Gross margin
N/A
Net margin
N/A
180 Life Sciences's net income has surged by 92% YoY and by 75% QoQ
180 Life Sciences's operating income has surged by 64% YoY and by 29% QoQ
Growth
What is 180 Life Sciences's growth rate over time
Valuation
What is 180 Life Sciences stock price valuation
P/E
0.29
P/B
0.59
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ATNF's EPS has surged by 149% since the previous quarter and by 103% year-on-year
The price to book (P/B) is 92% lower than the 5-year quarterly average of 8.1
Efficiency
How efficient is 180 Life Sciences business performance
The company's return on assets has surged by 82% YoY and by 81% QoQ
180 Life Sciences's return on equity has increased by 13% YoY
Dividends
What is ATNF's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATNF.
Financial health
How did 180 Life Sciences financials performed over time
The company's total assets is 55% higher than its total liabilities
The company's total assets has surged by 168% QoQ and by 111% YoY
The quick ratio has dropped by 95% year-on-year and by 90% since the previous quarter
ATNF's debt is 87% smaller than its equity
ATNF's debt to equity has soared by 112% since the previous quarter and by 105% year-on-year
ATNF's debt is up by 36% year-on-year and by 9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.